Cite
Short- and long-term biological variation of cardiac troponin I in healthy individuals, and patients with end-stage renal failure requiring haemodialysis or cardiomyopathy.
MLA
Lan, Nick S. R., et al. “Short- and Long-Term Biological Variation of Cardiac Troponin I in Healthy Individuals, and Patients with End-Stage Renal Failure Requiring Haemodialysis or Cardiomyopathy.” Clinical Chemistry & Laboratory Medicine, vol. 58, no. 11, Nov. 2020, pp. 1941–49. EBSCOhost, https://doi.org/10.1515/cclm-2020-0046.
APA
Lan, N. S. R., Nguyen, L. T., Vasikaran, S. D., Wilson, C., Jonsson, J., Rankin, J. M., & Bell, D. A. (2020). Short- and long-term biological variation of cardiac troponin I in healthy individuals, and patients with end-stage renal failure requiring haemodialysis or cardiomyopathy. Clinical Chemistry & Laboratory Medicine, 58(11), 1941–1949. https://doi.org/10.1515/cclm-2020-0046
Chicago
Lan, Nick S. R., Lan T. Nguyen, Samuel D. Vasikaran, Catherine Wilson, Jacqueline Jonsson, James M. Rankin, and Damon A. Bell. 2020. “Short- and Long-Term Biological Variation of Cardiac Troponin I in Healthy Individuals, and Patients with End-Stage Renal Failure Requiring Haemodialysis or Cardiomyopathy.” Clinical Chemistry & Laboratory Medicine 58 (11): 1941–49. doi:10.1515/cclm-2020-0046.